Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Leuprorelin acetate in addition to tamoxifen or an aromatase inhibitor for ER-positive early stage breast cancer in premenopausal women - adjuvant Leuprorelin acetate (Prostap DCS; Prostap Depot) , Tamoxifen Breast cancer Breast Cancer 2018 View  |  Download
Leuprorelin acetate for the preservation of ovarian function in premenopausal women with neoplastic disease undergoing chemotherapy Leuprorelin acetate (Prostap DCS; Prostap Depot) Ovarian function Breast Cancer , Gynaecology and Obstetrics 2018 View  |  Download
Leuprorelin acetate for advanced breast cancer in pre or perimenopausal women – adjuvant Leuprorelin acetate (Prostap DCS; Prostap Depot) Breast cancer Breast Cancer 2018 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications